These mice carry a transgene containing the Enhanced Green Fluorescent Protein driven by chicken beta-actin promoter and CMV intermediate early enhancer, which is integrated on the X chromosome. This strain may be a source of fluorescently marked cells/tissues.
Dr. Barbara Knowles, Institute of Medical Biology
Genetic Background | Generation |
---|---|
|
Allele Type |
---|
Transgenic (Reporter) |
This transgenic strain carries the Enhanced Green Fluorescent Protein (Clontech) driven by chicken beta-actin promoter and CMV intermediate early enhancer. The transgene was found to have integrated on the X chromosome. Mice of this strain, and cells derived from them, can be distinguished from wildtype on the basis of fluorescence. Transgene expression is seen as early as ~embryonic day 2.75, as morula stage embryos begin to compact. Expression of EGFP is spatiotemporally widespread, though levels differ between different lineages (e.g., expression is slightly higher in the heart). As the transgene is located on the X chromosome, transgenic males will exclusively transmit the EGFP transgene to their female offspring, providing the basis for a non-invasive sexing assay based on green fluorescence. The Donating Investigator reports that female homozygotes are not viable on this C57BL/6J congenic background. Hemizygous females on the congenic C57BL/6J background are viable and fertile. These mice may be useful for sex discrimination prior to overt sexual dimorphism (embryonic day 12.5), monitoring X-inactivation, and may be a source of fluorescently marked cells/tissues.
In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. This is the case for the strain above. It should be noted that the phenotype could vary from that originally described. We will modify the strain description if necessary as published results become available.
A transgenic construct containing an Enhanced Green Fluorescent Protein gene under the control of the a chicken beta actin promoter coupled with the cytomegalovirus (CMV) immediate early enhancer, was introduced into (129X1/SvJ x 129S1/Sv)F1-derived R1 embryonic stem (ES) cells. ES cells containing the construct were aggregated with ICR morulae and the resulting chimeric males were bred with ICR females for germline transmission. The transgenic offspring on the mixed background were intercrossed to generate homozygotes. Mice derived from founder line D4/XEGFP were sent to The Jackson Laboratory in 1998 and used to establish the colony on a mixed genetic background. The mice were then backcrossed to C57BL/6J for 8 to 10 generations. This transgene has been found to have integrated on the X chromosome.
Expressed Gene | GFP, Green Fluorescent Protein, |
---|---|
Site of Expression | Integration is on the X Chromosome. The transgene is expressed in a spatiotemporally ubiquitous manner, with expression being slightly higher in heart than in other tissues. Transgene expression is seen as early as ~E2.75. |
Allele Name | transgene insertion D4, Andras Nagy |
---|---|
Allele Type | Transgenic (Reporter) |
Allele Synonym(s) | D4/XEGFP; Tg(ACTB-EGFP)D4Nagy; Tg(CAG-EGFP)D4Nagy; Tg(CMV-GFP)1Jae; Tg(CMV-GFP)1Nagy; Tg(GFPX)4Nagy; XGFP; XGFP; X-GFP; Xp-GFP |
Gene Symbol and Name | Tg(CAG-EGFP)D4Nagy, transgene insertion D4, Andras Nagy |
Gene Synonym(s) | |
Promoter | ACTB, actin, beta, chicken |
Expressed Gene | GFP, Green Fluorescent Protein, |
Site of Expression | Integration is on the X Chromosome. The transgene is expressed in a spatiotemporally ubiquitous manner, with expression being slightly higher in heart than in other tissues. Transgene expression is seen as early as ~E2.75. |
Strain of Origin | (129X1/SvJ x 129S1/Sv)F1-Kitl+ |
Chromosome | X |
General Note | Transgene expression is seen as fluorescence under exposure to a 488 nm light source. In transgenic mice the reporter may be detected as early as ~E2.75, as morula stage embryos begin to compact. Expression of GFP is spatiotemporally ubiquitous, though levels differ between different lineages (e.g., expression is slightly higher in the heart). No discernible phenotype, other than green fluorescence, has been observed in any mice carrying this transgene. |
Molecular Note | The transgene contains the enhanced Green Fluorescent Protein driven by chicken beta-actin promoter and CMV intermediate early enhancer. Transgenic mice were generated by embryonic stem (ES) cell-mediated transgenesis. The construct was electroporated into R1 ES cells and random integration occurred on the X chromosome just distal of Timp and Syn1. |
Mutations Made By | Andras Nagy, Lunenfeld-Tanenbaum Research Institute (LTRI), Mount Sinai Hospital |
The strain is maintained by mating hemizygous females with wildtype males. This transgene is X-linked: therefore, this mating scheme generates hemizygous males (Tg/Y) and hemizygous females (Tg/+) along with wildtype controls (+/+ females and +/Y males). The Donating Investigator reports that female homozygotes are not viable on this genetic background.
When using the B6.129(Cg)-Tg(CAG-EGFP)D4Nagy/KnwJ mouse strain in a publication, please cite the originating article(s) and include JAX stock #018979 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
X linked Hemizygous females and non carrier Males for Tg(CAG-EGFP)D4Nagy |
Frozen Mouse Embryo | B6.129(Cg)-Tg(CAG-EGFP)D4Nagy/KnwJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129(Cg)-Tg(CAG-EGFP)D4Nagy/KnwJ Frozen Embryo | $2595.00 |
Frozen Mouse Embryo | B6.129(Cg)-Tg(CAG-EGFP)D4Nagy/KnwJ Frozen Embryo | $3373.50 |
Frozen Mouse Embryo | B6.129(Cg)-Tg(CAG-EGFP)D4Nagy/KnwJ Frozen Embryo | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.